141 related articles for article (PubMed ID: 6098328)
21. Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptors.
Di Paolo T; Daigle M; Labrie F
Psychoneuroendocrinology; 1984; 9(4):399-404. PubMed ID: 6514934
[TBL] [Abstract][Full Text] [Related]
22. Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex.
Meller E; Bohmaker K; Rosengarten H; Friedhoff AJ
Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):323-32. PubMed ID: 7178646
[TBL] [Abstract][Full Text] [Related]
23. Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
List SJ; Seeman P
Life Sci; 1979 Apr; 24(16):1447-52. PubMed ID: 470544
[No Abstract] [Full Text] [Related]
24. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
25. Hyperprolactinaemia does not alter specific striatal 3H-spiperone binding in the rat.
Simpson MD; Jenner P; Marsden CD
Biochem Pharmacol; 1986 Oct; 35(19):3203-8. PubMed ID: 3768017
[TBL] [Abstract][Full Text] [Related]
26. Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats.
Rosengarten H; Friedhoff AJ
Science; 1979 Mar; 203(4385):1133-5. PubMed ID: 570724
[TBL] [Abstract][Full Text] [Related]
27. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
[TBL] [Abstract][Full Text] [Related]
28. Social isolation and cohabitation with haloperidol-treated partners: effect on density of striatal dopamine D2 receptors in the developing rat brain.
Bean G; Lee T
Psychiatry Res; 1991 Mar; 36(3):307-17. PubMed ID: 1829534
[TBL] [Abstract][Full Text] [Related]
29. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain.
Kashihara K; Sato M; Fujiwara Y; Harada T; Ogawa T; Otsuki S
Biol Psychiatry; 1986 Jun; 21(7):650-6. PubMed ID: 3011131
[TBL] [Abstract][Full Text] [Related]
30. Striatal opiate mu-receptors are not located on dopamine nerve endings in the rat.
Trovero F; Herve D; Desban M; Glowinski J; Tassin JP
Neuroscience; 1990; 39(2):313-21. PubMed ID: 1982345
[TBL] [Abstract][Full Text] [Related]
31. Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain.
Reches A; Wagner HR; Barkai AI; Jackson V; Yablonskaya-Alter E; Fahn S
Psychopharmacology (Berl); 1984; 83(2):155-8. PubMed ID: 6431465
[TBL] [Abstract][Full Text] [Related]
32. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
Zharkovskiĭ AM; Matvienko OA; Nurk AM
Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
[TBL] [Abstract][Full Text] [Related]
33. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens.
Govoni S; Lucchi L; Missale C; Memo M; Spano PF; Trabucchi M
Brain Res; 1986 Aug; 381(1):138-42. PubMed ID: 3756492
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of chronic clorgyline and amfonelic acid on desensitization of striatal dopamine receptors.
Meller E; Bohmaker K; Friedhoff AJ
Life Sci; 1984 Oct; 35(18):1829-38. PubMed ID: 6492992
[TBL] [Abstract][Full Text] [Related]
35. Prenatal neuroleptic exposure alters postnatal striatal cholinergic activity in the rat.
Miller JC; Friedhoff AJ
Dev Neurosci; 1986; 8(2):111-6. PubMed ID: 2427306
[TBL] [Abstract][Full Text] [Related]
36. Chronic haloperidol administration increases the density of D2 dopamine receptors in the medial prefrontal cortex of the rat.
MacLennan AJ; Atmadja S; Lee N; Fibiger HC
Psychopharmacology (Berl); 1988; 95(2):255-7. PubMed ID: 3137606
[TBL] [Abstract][Full Text] [Related]
37. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Florijn WJ; Tarazi FI; Creese I
J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of postsynaptic dopamine receptors in the striatum does not influence haloperidol-induced catalepsy in mice.
Iwata S; Izumi K; Nomoto M
Pharmacol Biochem Behav; 1992 Aug; 42(4):803-8. PubMed ID: 1513862
[TBL] [Abstract][Full Text] [Related]
39. Role of assay conditions in determining agonist potency at D2 dopamine receptors in striatal homogenates.
de Vries DJ; Beart PM
Brain Res; 1986 Jul; 387(1):29-35. PubMed ID: 3742232
[TBL] [Abstract][Full Text] [Related]
40. Failure of chronic haloperidol to affect prolactin secretion due to acute haloperidol administration.
Parati EA; Parenti M; Locatelli V; Penalva A; Tamminga C; Müller EE
Pharmacol Res Commun; 1985 May; 17(5):407-15. PubMed ID: 4034625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
